4.7 Article

Phenanthroindolizidine Alkaloids Isolated from Tylophora ovata as Potent Inhibitors of Inflammation, Spheroid Growth, and Invasion of Triple-Negative Breast Cancer

期刊

出版社

MDPI
DOI: 10.3390/ijms231810319

关键词

triple-negative breast cancer (TNBC); phenanthroindolizidine alkaloids; O-methyltylophorinidine; nuclear factor kappa B (NF kappa B); hypoxia-inducible factor (HIF); tumor microenvironment (TME); 3D spheroid; cancer-associated fibroblast (CAF)

资金

  1. Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [SFB1450/1-431460824, EXC1003-194347757, GRK 2158, 270650915]
  2. Studienstiftung des Deutschen Volkes

向作者/读者索取更多资源

The study shows that phenanthroindolizidine alkaloids (PAs) can effectively block nuclear factor kappa B (NF kappa B), thus having the potential to combat triple-negative breast cancer (TNBC). Additionally, PAs demonstrate better therapeutic effects against TNBC compared to the gold standard drug paclitaxel.
Triple-negative breast cancer (TNBC), representing the most aggressive form of breast cancer with currently no targeted therapy available, is characterized by an inflammatory and hypoxic tumor microenvironment. To date, a broad spectrum of anti-tumor activities has been reported for phenanthroindolizidine alkaloids (PAs), however, their mode of action in TNBC remains elusive. Thus, we investigated six naturally occurring PAs extracted from the plant Tylophora ovata: O-methyltylophorinidine (1) and its five derivatives tylophorinidine (2), tylophoridicine E (3), 2-demethoxytylophorine (4), tylophoridicine D (5), and anhydrodehydrotylophorinidine (6). In comparison to natural (1) and for more-in depth studies, we also utilized a sample of synthetic O-methyltylophorinidine (1s). Our results indicate a remarkably effective blockade of nuclear factor kappa B (NF kappa B) within 2 h for compounds (1) and (1s) (IC50 = 17.1 +/- 2.0 nM and 3.3 +/- 0.2 nM) that is different from its effect on cell viability within 24 h (IC50 = 13.6 +/- 0.4 nM and 4.2 +/- 1 nM). Furthermore, NF kappa B inhibition data for the additional five analogues indicate a structure-activity relationship (SAR). Mechanistically, NF kappa B is significantly blocked through the stabilization of its inhibitor protein kappa B alpha (I kappa B alpha) under normoxic as well as hypoxic conditions. To better mimic the TNBC microenvironment in vitro, we established a 3D co-culture by combining the human TNBC cell line MDA-MB-231 with primary murine cancer-associated fibroblasts (CAF) and type I collagen. Compound (1) demonstrates superiority against the therapeutic gold standard paclitaxel by diminishing spheroid growth by 40% at 100 nM. The anti-proliferative effect of (1s) is distinct from paclitaxel in that it arrests the cell cycle at the G0/G1 state, thereby mediating a time-dependent delay in cell cycle progression. Furthermore, (1s) inhibited invasion of TNBC monoculture spheroids into a matrigel (R)-based environment at 10 nM. In conclusion, PAs serve as promising agents with presumably multiple target sites to combat inflammatory and hypoxia-driven cancer, such as TNBC, with a different mode of action than the currently applied chemotherapeutic drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据